Systematic Financial Management’s Albany Molecular Research Inc AMRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q1
– Sell
-171,916
Closed -$1.73M – 759
2013
Q4
$1.73M Buy
171,916
+55,725
+48% +$673K 0.01% 570
2013
Q3
$1.5M Sell
116,191
-259,780
-69% -$3.2M 0.01% 477
2013
Q2
$4.46M Buy
+375,971
New +$4.07M 0.04% 322

Other funds holding AMRI

Systematic Financial Management's AMRI Position: Q1 2014 in Review

Systematic Financial Management sold out of Albany Molecular Research Inc (AMRI) in Q1 2014, closing a stake of 171,916 shares — an estimated $1.73M sold.

Systematic Financial Management first reported a position in AMRI in Q2 2013 and held it in 3 quarters. The position peaked at $4.46M in Q2 2013. 113 funds tracked by Wall St. Rank hold AMRI as of Q1 2014.

  • Systematic Financial Management reported no remaining Albany Molecular Research Inc position as of Q1 2014 after selling out during the quarter.
  • Systematic Financial Management sold 171,916 Albany Molecular Research Inc shares in Q1 2014, an estimated $1.73M.
  • Systematic Financial Management first reported a position in Albany Molecular Research Inc in Q2 2013 and held it in 3 quarters.
  • Systematic Financial Management's Albany Molecular Research Inc position peaked at $4.46M in Q2 2013.
  • 113 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2014.

Based on Systematic Financial Management's 13F filing for Q1 2014, filed 15 May 2014.